Alstrom syndrome: insulin resistance in young with congestive heart failure

  • Khushboo AgarwalEmail author
  • Alok Gupta
  • Dhruv Thakur
  • Rajat Gupta
Case Report


Alstrom Hallgren syndrome is a rare ciliopathy first described in 1959. It is characterised by progressive cone-rod dystrophy leading to blindness, sensorineural hearing loss, childhood obesity and congestive heart failure. Its pathogenesis is related to development of insulin resistance, and type 2 diabetes mellitus. We report a case of a 20-year-old presenting with decompensated heart failure and had been blind since childhood who was eventually diagnosed as Alstrom syndrome based on clinical criteria.


Ciliopathy Congestive heart failure Insulin resistance Diabetes mellitus 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any use of animals or drugs by any of the authors.

Informed consent

The authors certify that they have obtained all the appropriate consent forms. In the form, the patient has given the consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal the identity, but anonymity cannot be guaranteed.


  1. 1. as accessed on 16/4/18.
  2. 2.
    Marshall JD, Beck S, Maffei P, Naggert JK. Alström syndrome. Eur J Hum Genet. 2007;15:1193–202.CrossRefGoogle Scholar
  3. 3.
    Alstrom CH, Hallgren B, Nilsson LB, Asander H. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Biedl syndrome. A clinical endocrinological and genetic examination based on a large pedigree. Acta Psychiatr Neurol Scand. 1959;34(suppl. 129):1–35.Google Scholar
  4. 4.
    Marshall JD, Maffei P, Collin GB, Naggert JK. Alström syndrome: genetics and clinical overview. Curr Genomics. 2011;12(3):225–35. Scholar
  5. 5.
    Marshall JD, Paisey RB, Carey C, et al. Alström syndrome. 2003 Feb 7 [updated 2012 May 31]. In: Adam MP, Ardinger HH, Pagon RA, et al. editors. GeneReviews® [Internet] Seattle (WA): University of Washington, Seattle; 1993–2018.Google Scholar
  6. 6.
    Bond J, Flintoff K, Higgins J, Scott S, Bennet C, Parsons J, et al. The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J Med Genet. 2005;42:e10.CrossRefGoogle Scholar
  7. 7.
    Marshall JD, Muller J, Collin GB, Milan G, Kingsmore SF, Dinwiddie D, et al. Alström syndrome: mutation spectrum of ALMS1. Hum Mutat. 2015;36(7):660–8.CrossRefGoogle Scholar
  8. 8.
    Scheinfeldt LB, Biswas S, Madeoy J, Connelly CF, Schadt EE, Akey JM. Population genomic analysis of ALMS1 in humans reveals a surprisingly complex evolutionary history. Mol Biol Evol. 2009;26(6):1357–67.CrossRefGoogle Scholar
  9. 9.
    Hoffman JD, Jacobson Z, Young TL, Marshall JD, Kaplan P. Familial variable expression of dilated cardiomyopathy in Alstrom syndrome: a report of four sibs. Am J Med Genet A. 2005;135:96–8.CrossRefGoogle Scholar
  10. 10.
    Duffy AJ, Panait L, Eisenberg D, Bell RL, Roberts KE, Sumpio B. Management of median arcuate ligament syndrome: a new paradigm. Ann Vasc Surg. 2009 Nov-Dec;23(6):778–84.CrossRefGoogle Scholar
  11. 11.
    Petrella S, Prates JC. Celiac trunk compression syndrome. A review. Int J Morphol. 2006;24(3):429–36.CrossRefGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2019

Authors and Affiliations

  1. 1.Department of MedicineDr S.N. Medical CollegeJodhpurIndia

Personalised recommendations